+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A
Mergers & Acquisitions | 17 August 2012

KKR, Novartis, Pfizer In Race To Acquire Strides' Unit

by Paritosh Gajjar
 
@Paritosh
Strides Arcolabs' injectable-drugs unit, @Agila_Specialties Private Limited is up for sale and 'serious bidders' for the asset are Novartis and @Pfizer_Limited along with U.S buyout fund KKR, ET stated.

Strides is expecting to receive anywhere between $1.6-2 Bn for the unit - more than twice its market value.

Strides provides Pfizer with generic versions of off-patent drugs through a partnership announced in 2010.

Orbit Corp To Raise Funds - Selling Multiple Projects

Orbit Corp is planning to sell multiple planned projects in Mumbai to raise funds and reduce debt, according to Mint.

Read More...

GE Energy Invests In Atria's Wind Power Projects

GE Energy Financial Services has invested an undisclosed amount picking up equity stake in three wind power projects being developed by Atria Power Corporation Limited.

Read More...
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.